AXL and lung adenocarcinoma: In H358ER erlotinib-resistant human lung adenocarcinoma cell line, with wild-type EGFR the overexpression of Axl was reported, however, the knockdown of Axl in this cell line did not restore sensitivity to erlotinib [94].